CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,070,838 | -6.3% | 76,008 | -23.5% | 0.01% | 0.0% |
Q2 2023 | $2,209,336 | -4.0% | 99,296 | -6.6% | 0.01% | -12.5% |
Q1 2023 | $2,302,371 | +28.2% | 106,296 | +20.2% | 0.01% | +14.3% |
Q4 2022 | $1,796,237 | -20.8% | 88,441 | 0.0% | 0.01% | -22.2% |
Q3 2022 | $2,268,000 | -15.0% | 88,441 | -21.2% | 0.01% | -10.0% |
Q2 2022 | $2,669,000 | +5.6% | 112,220 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $2,527,000 | +3.9% | 112,220 | -8.6% | 0.01% | +14.3% |
Q4 2021 | $2,432,000 | -4.4% | 122,808 | -5.0% | 0.01% | -12.5% |
Q3 2021 | $2,544,000 | -0.5% | 129,250 | +11.2% | 0.01% | 0.0% |
Q2 2021 | $2,557,000 | +33.2% | 116,237 | +44.0% | 0.01% | +14.3% |
Q1 2021 | $1,920,000 | -39.3% | 80,723 | -33.2% | 0.01% | -36.4% |
Q4 2020 | $3,161,000 | +0.3% | 120,834 | -33.2% | 0.01% | -8.3% |
Q3 2020 | $3,150,000 | +36.5% | 180,978 | +31.9% | 0.01% | +20.0% |
Q2 2020 | $2,307,000 | +44.6% | 137,183 | +2.3% | 0.01% | +25.0% |
Q1 2020 | $1,595,000 | -1.7% | 134,154 | 0.0% | 0.01% | +33.3% |
Q4 2019 | $1,623,000 | -47.0% | 134,154 | -38.1% | 0.01% | -50.0% |
Q3 2019 | $3,062,000 | – | 216,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |